Zika virus (ZIKV) is a global public health issue due to its association with severe 33 developmental disorders in infants and neurological disorders in adults. Because ZIKV uses 34 glycosylation of its envelope (E) protein to interact with host cell receptors to facilitate entry, 35 these interactions could also be important for designing therapeutics and vaccines. Due to a lack 36 of information about Asn-linked (N-glycans) on ZIKV E, we analyzed ZIKV E of various strains 37 derived from different cells. ZIKV E proteins are extensively modified with oligomannose-, 38 hybrid-and complex-N-glycans of a highly heterogeneous nature. Host cell-surface glycans 39 correlated strongly with the glycomic features of ZIKV E. Mechanistically, we discovered that 40 ZIKV N-glycans are important in viral pathogenesis, as mannose-specific C-type lectins DC-41 SIGN and L-SIGN mediate cell entry of ZIKV. Our findings represent the first detailed mapping 42 of N-glycans on ZIKV E of various strains and their functional significance. 43 44 16,21-23 . Loss of N-glycosylation motif on domain I of E protein results in impaired expression and 68
Introduction
Zika virus (ZIKV) is mainly transmitted to humans via infected mosquitoes, though other 46 transmission routes, such as through placenta and sexual intercourse can also occur 1,2 . Recently, 47 Unlike the African and Asian lineage strains, the N-glycans found on the E protein of the 148 Brazilian isolate SJRP were almost exclusively non-sialylated when produced in C6/36 and Vero 149 cells. In both of these cell lines, the major N-glycans found were Man 5 GlcNAc 2 (1579.9 m/z), 150 asialo-bi-antennary (2070.2 m/z), and core fucosylated asialo-bi-antennary (2244.3 m/z) N-151 glycans (Supplementary Fig. 4e ). When produced in LLC-MK2 cells, however, the N-glycan 152 profile of the E protein from the SJRP strain was comparable to the profiles found for the four 153 other strains, with the di-sialylated bi-antennary (2792.6 m/z) and the core-fucosylated (Supplementary Fig. 4e ). 161 The major proportion (> 5%) of N-glycan spectra at 3603.0 mz, 3241.8 mz, 2792.6 mz, 3964.2 162 mz, 1836.0 mz, and 2040.2 mz were identified on ZIKV E produced in these cell lines. These 163 heterogenous N-glycan structures of the studied ZIKV E include high (oligo)-mannose; these and 164 other N-glycans compositionally are predicted to include the residues N-acetylgalactosamine 165 (GalNAc), N-acetylglucosamine (GlcNAc), N-acetylneuraminic acid (NeuAc), galactose (Gal), 166 glucose (Glc), fucose (Fuc), and sialic acid. In addition, we found many other glycan forms with 167 high heterogeneity but smaller proportion (< 5%); these were not further characterized. These 168 data are indicative of high heterogeneity of structure and composition of N-glycans on ZIKV E 169 proteins ( Supplementary Table 2 ). Cell-surface glycosylation strongly correlates with glycomic features of ZIKV E protein 171 In order to identify the general patterns of endogenous glycans in ZIKV-producing cell surface 172 endogenous glycoproteins, a lectin array was used. This approach relies on specificities of 173 immobilized lectins that recognize specific glycan features on cell surface glycoproteins, 174 resulting in their binding to the array. These data revealed that different cell lines harbor 175 differential cell-surface glycosylation (Fig. 3) that might impact the glycosylation of the virus 176 produced in these cells. In general, the expression of several cell-surface glycan structures 177 correlated with viral N-glycan features ( Supplementary Table 3 ). Of interest, and as shown in We showed for the first time that ZIKV E, which is required for host cell receptor binding, is 215 differentially glycosylated in a cell-type different fashion. The N-glycosylation pattern on ZIKV 216 11 E is thought to be involved in viral infectivity, morphogenesis, protein folding, virus entry, and 217 tissue tropism among other functions. This has also been described for other viruses including ZIKV E, which were mostly decorated with bi-antennary di-sialylated and core-fucosylated 234 agalactosylated N-glycans ( Fig. 2-3, Supplementary Fig. 4 ). Collectively, these findings 235 indicate that not only virus characteristics; e.g. strain or lineage, but also host cell physiology has 236 an impact on the glycosylation pattern of ZIKV E which may affect viral pathogenesis of ZIKV 237 strains.
238
In the current study, we did not determine the location of the N-glycans on ZIKV E protein. We 239 predict that the processed complex (mammalian-derived virus) or paucimannose (insect-derived 240 virus) glycan is at position N154 which is not essential for virus production and spread in 241 mosquito or mammalian cells 48 , as the high mannose-type N-glycans have been reported to be 242 present at the N154 residue in DI domain of ZIKV E within the conserved glycosylation motif 243 N-X-S/T 25,49 . Moreover, Asian strains (including strains circulating in Southeast Asia, and South 244 and Central America) of ZIKV, but not African strains, contain the N154 glycosylation site of 245 the E protein ( Supplementary Fig. 1 ), which has been reported previously 50 . Contrasting the 246 four African and Asian lineage viruses, the Brazilian ZIKV isolate SJRP revealed only partial 247 similarities in N-glycosylation. SJRP was decorated only with non-sialylated N-glycans when 248 generated in both C6/36 and Vero cell lines, however, mostly with sialylated N-glycans in THP-249 1, SNB-19 and JEG-3 cells ( Fig. 2-3, Supplementary Fig. 4 ), suggesting that decoration of 250 ZIKV E with sialylated N-glycans may correlate with diverse tissue tropism of the virus. Taken 251 together, these findings lead us to hypothesize that the "N-glycotype" of the recently emergent 252 Asian strains is mediating the incidence of the new neuropathogenic potential of ZIKV infection.
253
The results of our study revealed high heterogeneity in structure and composition of the N-254 glycans linked to ZIKV E produced by both insect and various mammalian cells including 255 monocytes, placental, and neural cell types. The heterogeneity of N-glycan has also been linked 256 to DENV E protein in terms of structure and composition 23 . The N-glycan on DENV E protein 257 that is produced by mammalian cells is a mixture of high-mannose glycan and complex glycan. 
315
In conclusion, our findings provide a first-of-its-kind detailed repertoire of N-glycans linked to 316 the ZIKV envelope. To our knowledge, this is the first comprehensive mapping on the glycome 317 of ZIKV E in different physiologically relevant cell lines. Our study showed that the N-glycans 318 linked to ZIKV E produced by both insect and various mammalian cells are highly heterogenous 319 in structure and composition. Both African and Asian lineage strains showed very similar N-320 glycosylation patterns of ZIKV E. We also noticed that the N-glycan pattern of the ZIKV E 321 depends on not only virus strain characteristics but also on cell line type. We showed that ZIKV 332 The ZIKV stocks were produced in various cell lines derived from human (placenta, brain, and 333 monocytes), monkey, and insects ( Supplementary Table 1a maintained in respective medium containing 2% FBS containing respective medium. All the 361 cells lines were maintained at 37 °C in a CO2 incubator (except the C6/36 cells which were 362 maintained at 28 °C). For the large-scale virus production, all cells were maintained at 37 °C in 363 CO2 incubator for 3-4 days (except C6/36 cells which were maintained at 28 °C for 5-7 days) 364 until cytopathic effects were observed.
Cell lines and viruses

365
Immunofluorescence assay 366 The C6/36, Vero, and SNB-19 cells were grown on cover slips and mock-infected or infected 367 with various strains of ZIKV. After 24 hours post infection, cells were processed for indirect 368 immunofluorescence assay using the double-labelling method. Briefly, cells were fixed in 4% 369 paraformaldehyde and processed for immunofluorescence assay. The cells were blocked and 
378
Purification of ZIKV virus and isolation of E protein 379
A large stock of ZIKV viruses were purified using sucrose cushion in ultracentrifugation as 380 described in previous methods 26 . Briefly, culture supernatants were centrifuged at 6,000 rpm for 381 10 min, and a 0.45µm filter was used to remove cell debris. Virus-containing filtrate was layered 382 onto 20% (w/v) sucrose and subjected to ultracentrifugation at 100,715 × g, 4 °C for 3.5 hours.
383
Pellets were dissolved in 100 µl of NTE buffer (10 mM Tris-HCl, pH 8.0, 120 mM NaCl and 
